Atopic Dermatitis Archives - Page 3 of 5 - MPR

Atopic Dermatitis

Persistent Diarrhea, Delirium, and Beefy Tongue: Is It Pellagra?

A recently published report describes the case of a female patient who developed pellagra, a disease caused by severe niacin deficiency rarely seen in the US.   The 62-year-old patient presented to the emergency department (ED) complaining of diarrhea that had persisted for 2 months and occurred about 8 to 10 times per day. Two months…

Abrocitinib Effective in Second Phase 3 Atopic Dermatitis Trial

Pfizer announced positive topline results from the phase 3 JADE MONO-2 trial of abrocitinib, an oral Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis (AD). The multicenter, double-blind, placebo-controlled trial evaluated the efficacy and safety of abrocitinib in 391 patients aged ≥12 years with a minimum body weight of…

Baricitinib Added to Topical Steroids Beneficial in Atopic Dermatitis Trial

Adding baricitinib to topical corticosteroids significantly improved disease severity in adult patients with moderate to severe atopic dermatitis, according to top-line results from BREEZE-AD7 study. The phase 3 study included 300 patients who had been diagnosed with moderate to severe atopic dermatitis for at least 12 months and had an inadequate response to topical medications.…